Infusion of rituximab over 90 minutes on an out-patient basis is safe and improves resource utilization.
El-Agnaf
Moulod R
MR
McCoy
Cathy
C
Ong
Young-Lee
YL
Eswedi
Abdul-Hakeem
AH
Black
Barbra
B
Ramadan
Khaled M
KM
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D007262:Infusions, Intravenous; D008223:Lymphoma / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D000069283:Rituximab; D013997:Time Factors